NN INC (NNBR) stock intrinsic value fair value estimate & owner earnings analysis

NN, Inc. makes precision-engineered metal and plastic components — bearings, machined parts, electrical contacts and connectors, and precision-molded parts — sold into automotive, industrial, electrical distribution, aerospace/defense and medical end markets through two segments, Mobile Solutions and Power Solutions. In 2020 the company sold its former Life Sciences business (surgical and orthopedic implant tooling) for $757 million, which was its largest and most profitable unit. What remains is a smaller, thinner-margin precision manufacturer, and we have valued the company as it exists today rather than blending in the pre-sale results. Since that sale, the remaining business has struggled. Revenue has declined every year since 2022 (from roughly $499 million to about $422 million in 2025) as auto and industrial demand softened, and owner earnings — cash generated by the business after the reinvestment needed just to keep current plants running, employee stock compensation, and working-capital swings — were negative in four of the last five years. Heavy, recurring capital spending on tooling and machinery for auto and industrial programs has consistently outpaced what the business converts to free cash. Management has responded by closing two underperforming plants (in Juarez, Mexico and Dowagiac, Michigan) during 2024–2025 and pursuing new business wins in growth areas like electrical grid infrastructure, defense electronics and vehicle electrification; the first half of 2026 shows revenue up meaningfully versus the first half of 2025, which is an encouraging but still early sign. Two capital-structure facts weigh heavily on what is left for common shareholders. First, the company carries roughly $155–165 million of term loan and asset-based revolver debt, mostly maturing in 2029–2030. Second, and more importantly, in 2021 the company issued $65 million of Series D Perpetual Preferred Stock that sits ahead of common stock in any sale or liquidation. That preferred stock does not currently pay cash dividends; instead its liquidation value has been compounding at about 12% per year, growing its carrying value to roughly $112 million by the end of 2025, and its dividend rate is contractually set to keep escalating starting in 2026. Cash dividends on it become mandatory in September 2027, subject to what the company's lenders will allow. Because these preferred dividends accrue outside of cash flow (they are added to the preferred's balance rather than paid), they are not automatically captured by a cash-flow-based earnings measure, so we have treated the growing preferred claim as a separate deduction from what common shareholders can expect to receive — similar in spirit to how a large, growing IOU ahead of you in line reduces what's left for you, even if it isn't showing up in the checking account yet. Our bear case assumes the recent revenue uptick fades, auto and industrial markets stay weak, the plant closures' savings are largely absorbed by cost inflation, and owner earnings remain negative throughout the next decade while the preferred continues compounding largely unchecked. In this case, the business is worth less than what is owed to lenders and preferred holders combined — common shareholders would be left with nothing, and by our estimate the shortfall is on the order of $4 to $5 per share, meaning the company's debts and preferred claims exceed what the operating business is likely worth. Our base case assumes the new-business wins and completed cost cuts stabilize the business over the next several years, gradually lifting owner earnings from roughly breakeven today to a modest positive level, sustained by ongoing reinvestment in the kind of precision-machining capacity that lets the company keep re-winning multi-year auto, industrial and defense programs. Even so, the growing preferred claim consumes essentially all of the value that operating improvement would otherwise create, leaving base-case value for common shares at roughly break-even to slightly negative. Our bull case assumes the company successfully shifts its mix toward higher-margin electrical, defense and medical work, meaningfully expands margins, and — critically — refinances or redeems the preferred stock before its escalating terms do more damage; in that scenario we estimate the shares could be worth a little over $3.50. Because the base and bear cases come out at or below zero, no margin-of-safety price is assigned today; a share price alone is not the main constraint. What would need to change first is clear evidence that the Series D Preferred Stock has been redeemed, refinanced on materially better terms, or otherwise resolved, combined with several consecutive quarters of genuinely positive owner earnings (not just an accounting profit) — at that point the estimate would look very different and a margin-of-safety price could be set. We should note that a meaningful share of the bull-case value depends on the business sustaining a modest, steady level of earning power well beyond our ten-year forecast window; that assumption is reasonable if the recent operational turnaround holds, but it is not yet proven given the company's history of recurring restructuring charges. We found no going-concern warning or delisting notice in the most recent annual report, and the company reported compliance with its debt covenants as of the end of 2025, but the preferred stock's terms make this a business whose value to common shareholders depends heavily on resolving that overhang.